The Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc.

Pathologists can then test for BPDCN by testing for certain biomarkers which are highly expressed on BPDCN cells. Tagraxofusp-erzs is the only approved treatment for patients with BPDCN ...

Due to its aggressive nature and the immature cell involvement, the prognosis can be poor if not treated promptly," said Marina Konopleva, MD, Phd, Professor, Molecular Pharmacology, Director ...

Due to its aggressive nature and the immature cell involvement, the prognosis can be poor if not treated promptly," said Marina Konopleva, MD, Phd, Professor, Molecular Pharmacology, Director, ...

The American Red Cross Northern Ohio Region looks to draw 500 pints of blood each day, where it's then distributed to ...

Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.

Chundawat is a bioengineer and expert on protein engineering and glycosciences, the study of complex carbohydrates such as cellulose. To make the cells fluorescent and detectable by the microscope, he ...

Plasma physics is the study of a state of matter comprising charged particles. Plasmas are usually created by heating a gas until the electrons become detached from their parent atom or molecule ...